News

Slenyto is now available in South Korea!
Sep 25, 2024
Slenyto is now available in South Korea!

We are thrilled to announce the successful launch of Slenyto in South Korea on September 25th. This unique medication is set to make a significant impact, improving the lives of […]

Read more
Neurim’s satellite symposium at IPSA 2024
Apr 24, 2024
Neurim’s satellite symposium at IPSA 2024

Neurim Pharmaceuticals is attending IPSA 2024 Congress in Glasgow. We are delighted to invite IPSA 2024 attendees to participate in our satellite symposium “Advances in treatment of insomnia in children […]

Read more
Neurim’s Partners Meeting 2024
Apr 17, 2024
Neurim’s Partners Meeting 2024

We were thrilled to gather our international partners once more for a successful meeting focused on exchanging ideas and insights, all with the goal of promoting improved care for children […]

Read more
Neurim’s Partners Meeting 2023
Mar 23, 2023
Neurim’s Partners Meeting 2023

We were delighted to have our international partners together, for another successful meeting, sharing ideas and insights, aiming at promoting better care of insomnia in children with ASD.

Neurim’s satellite symposium at ESCAP 2022
Jun 14, 2022
Neurim’s satellite symposium at ESCAP 2022

We are delighted to invite ESCAP 2022 attendees to participate in our satellite symposium “Screen, Evaluate and Treat Insomnia in Children with ASD” on Monday, June 20th at 12:30. Symposium […]

Read more
Neurim’s Partners Meeting 2022
May 30, 2022
Neurim’s Partners Meeting 2022

We held our Annual Partners’ Meeting with our international colleagues, sharing insights and ideas for better care of insomnia in ASD children.      

Slenyto is now available in Spain!
Mar 17, 2022
Slenyto is now available in Spain!

We are excited to announce that as of March Slenyto is also available in Spain for the treatment of insomnia in children with ASD.